{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-006801","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2022-10-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.336338+00:00","generated_at":"2026-06-23T04:39:40.918524+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sonoma Pharmaceuticals appoints Chad White as CFO, succeeding Jerry Dvonch effective Nov 18, 2022","bullets":["Jerry Dvonch resigns as CFO effective Nov 18, 2022; will assist transition to Boulder, CO office by Dec 31.","Chad White appointed interim CFO Oct 3 and permanent CFO Nov 18; previously CFO at Slumber Cloud and Outlast Technologies.","White receives $230,000 annual salary, bonus up to 50% of salary, and options for 5,000 shares vesting over 3 years.","Company closing Woodstock, GA office; operations to be centralized in Boulder, CO."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-006801","json":"https://secwatch.observer/filing/0001683168-22-006801.json","markdown":"https://secwatch.observer/filing/0001683168-22-006801.md","text":"https://secwatch.observer/filing/0001683168-22-006801.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/snoa_i8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:39:40.918524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"10c04f742d","claim":"Chad White was appointed as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"Effective on October 3, 2022, our Board of Directors appointed Chad White as our interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"2fc08b641b","claim":"Jerry Dvonch resigned as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"We accepted the resignation of Mr. Dvonch as Chief Financial Officer effective November 18, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"47160ceda2","claim":"Chad White changed role as Chief Financial Officer at Sonoma Pharmaceuticals, Inc..","evidence_excerpt":"Effective November 18, 2022, Mr. White will serve as Chief Financial Officer of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822006801/0001683168-22-006801-index.htm","confidence":0.8,"family_label":"Executive change","details":[{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}